Imsidolimab
ANB019-206
Phase 2 small_molecule terminated
Quick answer
Imsidolimab for Ichthyosis is a Phase 2 program (small_molecule) at Vanda Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Vanda Pharmaceuticals
- Indication
- Ichthyosis
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated